Cargando…

Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension

Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume e...

Descripción completa

Detalles Bibliográficos
Autores principales: Matanes, Faris, Siddiqui, Mohammed, Velasco, Alejandro, Sharifov, Oleg, Kreps, Eric, Dudenbostel, Tanja, Judd, Eric K, Zhang, Bin, Lloyd, Steven G, Oparil, Suzanne, Calhoun, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184488/
https://www.ncbi.nlm.nih.gov/pubmed/37013369
http://dx.doi.org/10.1111/jch.14625
_version_ 1785042162723848192
author Matanes, Faris
Siddiqui, Mohammed
Velasco, Alejandro
Sharifov, Oleg
Kreps, Eric
Dudenbostel, Tanja
Judd, Eric K
Zhang, Bin
Lloyd, Steven G
Oparil, Suzanne
Calhoun, David A
author_facet Matanes, Faris
Siddiqui, Mohammed
Velasco, Alejandro
Sharifov, Oleg
Kreps, Eric
Dudenbostel, Tanja
Judd, Eric K
Zhang, Bin
Lloyd, Steven G
Oparil, Suzanne
Calhoun, David A
author_sort Matanes, Faris
collection PubMed
description Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non‐RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non‐resistant hypertension (CHTN), defined as BP controlled with ≤3 anti‐hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN.
format Online
Article
Text
id pubmed-10184488
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101844882023-05-16 Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension Matanes, Faris Siddiqui, Mohammed Velasco, Alejandro Sharifov, Oleg Kreps, Eric Dudenbostel, Tanja Judd, Eric K Zhang, Bin Lloyd, Steven G Oparil, Suzanne Calhoun, David A J Clin Hypertens (Greenwich) Resistant Hypertension Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long‐acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so‐called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non‐RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non‐resistant hypertension (CHTN), defined as BP controlled with ≤3 anti‐hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN. John Wiley and Sons Inc. 2023-04-03 /pmc/articles/PMC10184488/ /pubmed/37013369 http://dx.doi.org/10.1111/jch.14625 Text en © 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Resistant Hypertension
Matanes, Faris
Siddiqui, Mohammed
Velasco, Alejandro
Sharifov, Oleg
Kreps, Eric
Dudenbostel, Tanja
Judd, Eric K
Zhang, Bin
Lloyd, Steven G
Oparil, Suzanne
Calhoun, David A
Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title_full Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title_fullStr Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title_full_unstemmed Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title_short Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
title_sort adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
topic Resistant Hypertension
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184488/
https://www.ncbi.nlm.nih.gov/pubmed/37013369
http://dx.doi.org/10.1111/jch.14625
work_keys_str_mv AT matanesfaris adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT siddiquimohammed adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT velascoalejandro adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT sharifovoleg adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT krepseric adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT dudenbosteltanja adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT judderick adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT zhangbin adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT lloydsteveng adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT oparilsuzanne adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension
AT calhoundavida adversecardiacremodelingisabsentinpatientswithtruecontrolledresistanthypertension